Medicare Enrolled
Dr. Andrew Win, MD
Cardiovascular Disease · New Bern, NC
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Win from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Win?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Win
Dr. Andrew Win is a cardiovascular disease specialist in New Bern, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Win performed 4,851 Medicare services across 3,004 unique beneficiaries.
Between the years covered by Open Payments, Dr. Win received a total of $12,016 from 50 pharmaceutical and/or device companies across 822 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Win is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in NC
$12,016 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,851
Medicare services
Top 9% in NC for cardiovascular disease
3,004
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~243 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,623 | $91 | $246 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
797 | $10 | $60 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
523 | $6 | $25 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
429 | $43 | $89 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
363 | $84 | $249 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
250 | $133 | $1,100 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
170 | $325 | $1,300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
158 | $60 | $130 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
112 | $47 | $315 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
71 | $99 | $245 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
58 | $20 | $65 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $119 | $310 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
33 | $161 | $1,000 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
32 | $16 | $80 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
32 | $11 | $75 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
31 | $34 | $315 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
28 | $16 | $285 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
22 | $8 | $35 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
16 | $8 | $35 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
15 | $18 | $85 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $68 | $174 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
13 | $82 | $458 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. The procedure uses special cameras to create images of the heart's function. |
12 | $235 | $767 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
25.3% medium
68.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,016
Total received (2018-2024)
Avg $1,717/year across 7 years
Top 22% in NC for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
822
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,016 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,690
2023
$1,745
2022
$2,401
2021
$2,030
2020
$1,321
2019
$1,456
2018
$1,374
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$217
E.R. Squibb & Sons, L.L.C.
$182
Merck Sharp & Dohme LLC
$169
Janssen Pharmaceuticals, Inc
$122
SANOFI-AVENTIS U.S. LLC
$113
Actelion Pharmaceuticals US, Inc.
$105
Novo Nordisk Inc
$92
Baxter Healthcare
$78
iRhythm Technologies, Inc.
$70
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$70
Lexicon Pharmaceuticals, Inc.
$68
United Therapeutics Corporation
$65
Amgen Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Bayer Healthcare Pharmaceuticals Inc.
$37
Daiichi Sankyo Inc.
$37
MEDICOMP INC
$27
Medtronic, Inc.
$25
Kiniksa Pharmaceuticals International, plc
$23
AstraZeneca Pharmaceuticals LP
$20
PFIZER INC.
$18
Alnylam Pharmaceuticals Inc.
$17
SCPHARMACEUTICALS INC.
$17
Kowa Pharmaceuticals America, Inc.
$14
VivaQuant Inc, dba Rhythm Express
$12
Top 3 companies account for 33.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,468
Novartis Pharmaceuticals Corporation
$1,109
Amgen Inc.
$989
Actelion Pharmaceuticals US, Inc.
$988
SANOFI-AVENTIS U.S. LLC
$925
E.R. Squibb & Sons, L.L.C.
$844
Boehringer Ingelheim Pharmaceuticals, Inc.
$561
AstraZeneca Pharmaceuticals LP
$533
Merck Sharp & Dohme LLC
$482
Amarin Pharma Inc.
$477
Abbott Laboratories
$376
iRhythm Technologies, Inc.
$268
PFIZER INC.
$263
Novo Nordisk Inc
$259
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$254
Kowa Pharmaceuticals America, Inc.
$191
Bayer HealthCare Pharmaceuticals Inc.
$175
Daiichi Sankyo Inc.
$158
United Therapeutics Corporation
$153
Medtronic, Inc.
$141
Esperion Therapeutics, Inc.
$137
Merck Sharp & Dohme Corporation
$123
Regeneron Healthcare Solutions, Inc.
$98
Lundbeck LLC
$80
Baxter Healthcare
$78
Lexicon Pharmaceuticals, Inc.
$68
Astellas Pharma US Inc
$67
Bayer Healthcare Pharmaceuticals Inc.
$65
Medtronic Vascular, Inc.
$64
Gilead Sciences, Inc.
$63
Edwards Lifesciences Corporation
$62
CARDIVA MEDICAL, INC.
$52
Kiniksa Pharmaceuticals, Ltd.
$50
MEDICOMP INC
$48
ARBOR PHARMACEUTICALS, INC.
$42
Boston Scientific Corporation
$41
Alnylam Pharmaceuticals Inc.
$37
BIOTRONIK INC.
$30
Relypsa, Inc.
$27
Kiniksa Pharmaceuticals International, plc
$23
GENZYME CORPORATION
$19
SCPHARMACEUTICALS INC.
$17
CVRx, Inc.
$17
G Medical Diagnostic Services, Inc.
$15
Tactile Systems Technology Inc
$14
LeMaitre Vascular, Inc.
$14
Arbor Pharmaceuticals, Inc.
$13
Allergan Inc.
$13
VivaQuant Inc, dba Rhythm Express
$12
Sun Pharmaceutical Industries Inc.
$11
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
Arcalyst · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CHANTIX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FABRY-DISEASE · FARXIGA · FLEXITOUCH · FUROSCIX · GENERAL PAIN MANAGEMENT · GENERAL - THERAPIES · HeartMate · Hillrom - Cardiac Ambulatory Monitor · Horizant · INJECTAFER · JARDIANCE · KAPSPARGO · KEVZARA SARILUMAB INJECTION · Kerendia · LEQVIO · LEXISCAN · LIVALO · LifeVest · Livalo · MITRACLIP · MULTAQ · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Repatha · Reveal LINQ · Rhythm Express · Rybelsus · SAPIEN 3 Ultra RESILIA · TELEPATCH CARDIAC MONITOR · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WINREVAIR · Wegovy · XARELTO · XENOSURE · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
19
Per 100K population
18.8
County median income
$64,635
Nearest hospital
CAROLINA EAST MEDICAL CENTER
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Win is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 9% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Win experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Win performed 1,623 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Win receive payments from pharmaceutical companies?
Yes. Dr. Win received a total of $12,016 from 50 companies across 822 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Win's costs compare to other cardiologists in New Bern?
Dr. Win's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Win) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in New Bern
Browse cardiologists in New Bern ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NC
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NC
Which NC cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology